Adam Bress
Cited by
Cited by
Association of blood pressure classification in young adults using the 2017 American College of Cardiology/American Heart Association blood pressure guideline with …
Y Yano, JP Reis, LA Colangelo, D Shimbo, AJ Viera, NB Allen, ...
Jama 320 (17), 1774-1782, 2018
Generalizability of SPRINT results to the US adult population
AP Bress, RM Tanner, R Hess, LD Colantonio, D Shimbo, P Muntner
Journal of the American College of Cardiology 67 (5), 463-472, 2016
Left atrial fibrosis and risk of cerebrovascular and cardiovascular events in patients with atrial fibrillation
JB King, PN Azadani, P Suksaranjit, AP Bress, DM Witt, FT Han, ...
Journal of the American College of Cardiology 70 (11), 1311-1321, 2017
Cost-effectiveness of intensive versus standard blood-pressure control
AP Bress, BK Bellows, JB King, R Hess, S Beddhu, Z Zhang, DR Berlowitz, ...
New England Journal of Medicine 377 (8), 745-755, 2017
Cost-effectiveness of sacubitril-valsartan combination therapy compared with enalapril for the treatment of heart failure with reduced ejection fraction
JB King, RU Shah, AP Bress, RE Nelson, BK Bellows
JACC: Heart Failure 4 (5), 392-402, 2016
The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy
D Brixner, E Biltaji, A Bress, S Unni, X Ye, T Mamiya, K Ashcraft, ...
Journal of medical economics 19 (3), 213-228, 2016
Potential deaths averted and serious adverse events incurred from adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) intensive blood pressure regimen in the …
AP Bress, H Kramer, R Khatib, S Beddhu, AK Cheung, R Hess, VK Bansal, ...
Circulation 135 (17), 1617-1628, 2017
Trends in antihypertensive medication discontinuation and low adherence among Medicare beneficiaries initiating treatment from 2007 to 2012
GS Tajeu, ST Kent, IM Kronish, L Huang, M Krousel-Wood, AP Bress, ...
Hypertension 68 (3), 565-575, 2016
Neprilysin inhibition in heart failure with reduced ejection fraction: a clinical review
JB King, AP Bress, AD Reese, MA Munger
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (9 …, 2015
Effects of intensive systolic blood pressure lowering on cardiovascular events and mortality in patients with type 2 diabetes mellitus on standard glycemic control and in those …
S Beddhu, GM Chertow, T Greene, PK Whelton, WT Ambrosius, ...
Journal of the American Heart Association 7 (18), e009326, 2018
Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans
K Drozda, S Wong, SR Patel, AP Bress, EA Nutescu, RA Kittles, ...
Pharmacogenetics and genomics 25 (2), 73, 2015
Effect of intensive versus standard blood pressure treatment according to baseline prediabetes status: a post hoc analysis of a randomized trial
AP Bress, JB King, KE Kreider, S Beddhu, DL Simmons, AK Cheung, ...
Diabetes Care 40 (10), 1401-1408, 2017
Feasibility of implementing a comprehensive warfarin pharmacogenetics service
EA Nutescu, K Drozda, AP Bress, WL Galanter, J Stevenson, TD Stamos, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33 (11 …, 2013
Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic–Americans and African–Americans
A Bress, SR Patel, MA Perera, RT Campbell, RA Kittles, LH Cavallari
Pharmacogenomics 13 (16), 1925-1935, 2012
Revisiting warfarin dosing using machine learning techniques
A Sharabiani, A Bress, E Douzali, H Darabi
Computational and mathematical methods in medicine 2015, 2015
Trends in antihypertensive medication monotherapy and combination use among US adults, National Health and Nutrition Examination Survey 2005–2016
CG Derington, JB King, JS Herrick, D Shimbo, IM Kronish, JJ Saseen, ...
Hypertension 75 (4), 973-981, 2020
Intensive vs standard blood pressure control in adults 80 years or older: a secondary analysis of the systolic blood pressure intervention trial
NM Pajewski, DR Berlowitz, AP Bress, KE Callahan, AK Cheung, LJ Fine, ...
Journal of the American Geriatrics Society 68 (3), 496-504, 2020
Role of cytochrome P450 genotype in the steps toward personalized drug therapy
LH Cavallari, H Jeong, A Bress
Pharmacogenomics and personalized medicine, 123-136, 2011
2017 ACC/AHA blood pressure treatment guideline recommendations and cardiovascular risk
LD Colantonio, JN Booth, AP Bress, PK Whelton, D Shimbo, EB Levitan, ...
Journal of the American College of Cardiology 72 (11), 1187-1197, 2018
Potential cardiovascular disease events prevented with adoption of the 2017 American College of Cardiology/American Heart Association blood pressure guideline
AP Bress, LD Colantonio, RS Cooper, H Kramer, JN Booth III, MC Odden, ...
Circulation 139 (1), 24-36, 2019
The system can't perform the operation now. Try again later.
Articles 1–20